Sung Lee
EVP, Chief Financial Officer · CYTOKINETICS INC
- 2024
- Jul 2, 2026
- 12
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Sung Lee files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Robert I. Blum - $17.76M in CYTK purchases and sales in the last 12 months
- Andrew Callos - $11.01M in CYTK purchases and sales in the last 12 months
- Adam Crystal - $6.99M in TNGX purchases and sales in the last 12 months
- Third Rock Ventures IV, L.P. - $4.85M in TNGX purchases and sales in the last 12 months
- Fady Ibraham Malik - $4.75M in CYTK purchases and sales in the last 12 months
- Edward M. Md Kaye - $2.43M in CYTK purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Sung Lee?
Sung Lee is a corporate insider, tracked as EVP, Chief Financial Officer of CYTOKINETICS INC (CYTK). InsiderAlpha holds 12 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Sung Lee last file a Form 4?
The most recent primary Form 4 on record is dated 2 July 2026, one of 12 filings going back to 2024.
Has Sung Lee been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($2.51M) across all tracked filings.
